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• Pregnancy is associated with an increased risk of stroke in 
young women
• Idiopathic moyamoya syndrome (IMMS) is a rare condition 
characterized by progressive narrowing of large cerebral arteries 
resulting in flimsy collaterals prone to rupture or thrombosis
• Data are limited on pregnancy outcomes in women with IMMS
• We hypothesized that IMMS would be associated with increased 
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• Using the New York State Department of Health Statewide 
Planning and Research Cooperative System data from 2000-2014 
and the International Classification for Diseases Ninth Edition 
(ICD-9), we identified all women aged 18 and older with diagnoses 
of IMMS (ICD-9 437.5) who had hospitalizations for delivery at any 
time either prior, concomitant or subsequent to IMMS diagnosis
• We excluded patients with Down syndrome (ICD-9 758.0), 
neurofibromatosis type 1 (ICD-9 237.71) and sickle cell disease 
(ICD-9 282.6) at time of IMMS diagnosis
• We then aggregated all pregnancies for these identified patients 
occurring between January 1, 1994 to December 31, 2014
• Pregnancies were considered exposed if IMMS diagnosis 
occurred prior to or within 1 year of delivery
• Intermediate unexposed pregnancies were those within 2-5 
years prior IMMS diagnosis
• Unexposed pregnancies occurred 6 or more years prior IMMS 
diagnosis
• Pregnancy morbidity was defined as admission within 1 year of 
delivery for any of the Center for Disease Control and Prevention’s 
severe maternal morbidity indicators, including stroke
• We compared the morbidity of IMMS-exposed pregnancies to 
intermediate unexposed and unexposed pregnancies
• Generalized estimating equations were used to calculate odds 
ratio (OR) and 95% confidence intervals (95%CI) as well as adjust 
for women with multiple pregnancies occurring in both exposed 
and unexposed periods
Maternal morbidity outcomes in idiopathic moyamoya syndrome in New York State
• Pregnancies within 1 year prior 
or any time after IMMS 
diagnosis did not have 
increased maternal morbidity 
compared to unexposed 
pregnancies after adjusting for 
age and clustering of women 
with multiple pregnancies
• Prospective studies are needed 
to better characterize increased 
maternal risks for women with 
moyamoya syndrome and 
develop preventive strategies
• We identified 134 patients with 
264 pregnancies in total
• A majority of pregnancies were 
unexposed (45.1%, n=119) 
compared to exposed (31.4%, 
n= 83) and intermediate 
unexposed (23.4%, n=62)
• There were 23 (17.1%) women 
that had both exposed and 
unexposed pregnancies 
• Severe maternal morbidity was 
highest for exposed pregnancies 
compared to intermediate 
unexposed and unexposed 
(34.9% vs. 27.4% vs 17.7%; 
p=0.0003)
• After adjusting for age and 
multiple pregnancies, there were 
no significant odds of severe 
maternal morbidity or stroke in 
exposed pregnancies compared 
to unexposed pregnancies (OR: 
2.3, 95% CI: 0.8-6.9)
Table 1: Population demographics 
and characteristics





N (%) N (%) N (%)
Age (Mean + Standard deviation) 26.2 + 7.3 32.2 + 7.3 39.0 + 8.0
Insurance Status
Medicare/Medicaid 21 (25.3%) 15 (24.2%) 19 (16.0%) 0.01
Private 11 (13.3%) 1 (1.6%) 6 (5.0%)
Other 51 (61.4%) 46 (74.2%) 94 (79.0%)
Pregnancy Number
1 (First pregnancy) 28 (20.9%) 35 (26.1%) 71 (53.0%) <.0001
2 (Second pregnancy) 21 (33.9%) 12 (19.4%) 29 (46.8%)
3+ (Third or greater pregnancy) 34 (50.0%) 15 (22.1%) 19 (27.9%)
CDC indicator 25 (30.1%) 15 (24.2%) 19 (16.0%) 0.001
Stroke 6 (7.2%) 2 (3.2%) 3 (2.5%) 0.02
CDC indicator and/or stroke 29 (34.9%) 17 (27.4%) 21 (17.7%) 0.0003
Death 1 (1.2%) 0 (0.0%) 0 (0.0%) 0.3
ECIC 10 (12.1%) 0 (0.0%) 0 (0.0%) <.0001
C section 38 (45.8%) 27 (43.6%) 9 (7.6%) <.0001












Fig 2. Distribution of exposed and 
unexposed pregnancies 
852 IMMS patients from 
2000-2014 
626 MMS adults (18+) 
Excluded: 226 children (<18 years old)
554 idiopathic MMS adults 
(18+) 
Excluded: 72 secondary causes 
Sickle cell disease (n=60)
Down Syndrome (n=9)
Neurofibromatosis Type 1 (n=3)
386 IMMS women
Excluded: 168 men
134 IMMS parous women
Excluded: 252 nulliparous women
Table 3: Adjusted GEE models OR (95% CI) P-value
Age, CDC and stroke (ref = unexposed) 
Exposed 2.3 (0.8-6.9) 0.1
Intermediate unexposed 1.6 (0.6-4.1) 0.4
Table 2: Racial distribution of IMMS 
parous women
N (%)
Non-Hispanic White 51 (38.1%)
Non-Hispanic Black 27(20.1%)
Hispanic 19 (14.2%)
Other 24 (17.9%)
Asian 13 (9.7%)
